DoubleVerify's nomination for a Digiday award spotlights its News Accelerator initiative, a strategic push to bolster quality journalism and advertiser confidence in digital news environments. The move comes as the industry grapples with brand safety and seeks more transparent ad placements.
Amneal Pharmaceuticals' shares have surged over 64% in the past year, prompting investors to question if the rally still has room to run. A closer look at valuation metrics suggests the generic drugmaker may still be trading at a significant discount to its intrinsic value.
Paramount Skydance is launching a new programmatic advertising platform for live sports on Paramount+ and initiating a quarterly dividend, signaling a strategic shift towards monetizing its existing audience amid ongoing financial pressures.
New satellite imagery shows Iran constructing roofs over bomb-damaged buildings at its Isfahan and Natanz nuclear facilities, a move analysts say is likely aimed at shielding recovery efforts from surveillance as international pressure mounts over Tehran's internal crackdown and nuclear ambitions.
Despite a sharp pullback following gold's price dip, analysts remain bullish on SSR Mining, citing strong earnings potential and attractive valuation metrics even after its stellar run.
Three years after securing $1.3 billion in state incentives, Volkswagen-backed Scout Motors' planned electric vehicle factory faces mounting public costs amid wetland mitigation and inflation, raising questions about risk allocation.
U.S. producer prices rose more than expected in December, driven by the largest increase in service costs in months, complicating the inflation outlook as the Federal Reserve weighs its next policy move.
The FDA clearance of Spectrum Dynamics' Veritas.AI platform marks a significant step forward for nuclear imaging, promising to cut scan times in half and enhance image clarity for critical applications like cancer theranostics.
Charter Communications shares surged Friday after the cable giant reported a rare quarterly gain in pay-TV subscribers, a bright spot amid ongoing broadband pressures. The company's strategy of bundling streaming services appears to be resonating with customers.
President Donald Trump's selection of former Fed Governor Kevin Warsh to lead the central bank is widely seen as a move to accelerate the rollback of post-crisis financial rules and align regulatory policy more closely with White House objectives, analysts say.
Canadian National Railway reported increased traffic, revenue, and operating income for the fourth quarter of 2025, citing productivity gains and a recovery from prior-year port disruptions. However, executives warn that ongoing U.S. trade policy uncertainty and tariffs continue to cloud the outlook for 2026.
Venture capitalist Chamath Palihapitiya scored a monumental win with Nvidia's $20.6 billion purchase of AI chipmaker Groq, yet the investor reveals a profound sense of melancholy, highlighting the psychological complexities behind blockbuster deals.
As sky-high valuations plague pure-play AI stocks, a global industrial landlord is emerging as a critical—and potentially undervalued—enabler of the artificial intelligence boom through its strategic pivot into data centers.
Investment firm Elevation Capital has significantly increased its stake in the VanEck Fallen Angel High Yield Bond ETF (ANGL), a fund targeting corporate bonds downgraded from investment grade, signaling a strategic bet on higher yields in a shifting credit environment.
Stockholders of CSG Systems International have overwhelmingly approved a slate of key proposals, including governance changes and merger-related actions, during a recent virtual Extraordinary General Meeting. The approvals pave the way for the company's next phase of strategic growth.
Regeneron Pharmaceuticals reported a steady finish to 2025, driven by growth in key drugs Dupixent and EYLEA HD. While navigating competitive pressures on its legacy blockbuster, the biotech giant outlined an ambitious 2026 strategy focused on regulatory milestones and a broad clinical pipeline.
John B. Sanfilippo & Son posts record revenue and a 32% jump in EPS for fiscal Q2 2026, even as higher nut costs and shifting consumer habits pressure sales volumes. The snack nut processor eyes future growth through operational efficiency and new bar production capacity.
Gentex Corporation delivered a mixed 2025, with Q4 results buoyed by its Vox acquisition and improved core profitability, while tariffs on China exports continued to pressure sales. The automotive tech supplier provided a roadmap focused on advanced mirrors, sensing, and new electrochromic applications like dimmable visors.
Primis Financial (FRST) posted Q4 earnings of $29.5M, buoyed by a one-time gain. Management pegs core quarterly earnings near $8M, citing mortgage growth and deposit mix improvements as key drivers for its 2026 profitability target.
Shares of USA Rare Earth (NASDAQ: USAR) recovered Wednesday following a sharp sell-off, buoyed by an analyst's upgraded price target and reinforced by a recent $3.5 billion capital infusion from public and private sources.
